#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape | The Peter Attia Drive - Private Subscriber Feed (🔓 for Vijay Khakhria) | Podwise